Plasmodium vivax is the most widespread human malaria, putting 2.5 billion people at risk of
infection. Its unique biological and epidemiological characteristics pose challenges to …

Despite substantial scientific progress over the past two decades, malaria remains a
worldwide burden that causes hundreds of thousands of deaths every year. New, affordable …

Background Current understanding of the spatial epidemiology and geographical
distribution of Plasmodium vivax is far less developed than that for P. falciparum …

The first symptoms of malaria, common to all the different malaria species, are nonspecific
and mimic a flu-like syndrome. Although fever represents the cardinal feature, clinical …

Plasmodium vivax is geographically the most widely distributed cause of malaria in people,
with up to 2· 5 billion people at risk and an estimated 80 million to 300 million clinical cases …

Background Comprehensive and contemporary estimates of the number of pregnancies at
risk of malaria are not currently available, particularly for endemic areas outside of Africa …

Background A research priority for Plasmodium vivax malaria is to improve our
understanding of the spatial distribution of risk and its relationship with the burden of P. vivax …

Background Multidrug-resistant Plasmodium vivax (Pv) is widespread in eastern Indonesia,
and emerging elsewhere in Asia-Pacific and South America, but is generally regarded as a …

Protozoan Plasmodium parasites are the causative agents of malaria, a deadly disease that
continues to afflict hundreds of millions of people every year. Infections with malaria …

In the past 150 years, roughly half of the countries in the world eliminated malaria.
Nowadays, there are 99 endemic countries—67 are controlling malaria and 32 are pursuing …